D.E. Shaw & Co
STAB

D.E. Shaw & Co’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

D.E. Shaw & Co’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,352
Closed -$31K – 4330
2014
Q3 		$31K Hold
3,352
– – ﹤0.01% 4034
2014
Q2 		$32K Hold
3,352
– – ﹤0.01% 4122
2014
Q1 		$46K Sell
3,352
-215
-6% -$3.5K ﹤0.01% 4204
2013
Q4 		$83K Hold
3,567
– – ﹤0.01% 4381
2013
Q3 		$111K Hold
3,567
– – ﹤0.01% 4179
2013
Q2 		$113K Buy
+3,567
New +$123K ﹤0.01% 3860

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

D.E. Shaw & Co's STAB Position: Q4 2014 in Review

D.E. Shaw & Co sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2014, closing a stake of 3,352 shares — an estimated $31K sold.

D.E. Shaw & Co first reported a position in STAB in Q2 2013 and held it in 6 quarters. The position peaked at $113K in Q2 2013. 24 funds tracked by Wall St. Rank hold STAB as of Q4 2014.

  • D.E. Shaw & Co reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,352 Statera Biopharma, Inc. Common Stock shares in Q4 2014, an estimated $31K.
  • D.E. Shaw & Co first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 6 quarters.
  • D.E. Shaw & Co's Statera Biopharma, Inc. Common Stock position peaked at $113K in Q2 2013.
  • 24 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2014.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.